You have 9 free searches left this month | for more free features.

non-vasospastic subjects

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Aneurysmal Subarachnoid Hemorrhage, Vasospasm, Intracranial, Stenosis Trial in Brussel (Chemical and Mechanical Angioplasty for

Recruiting
  • Aneurysmal Subarachnoid Hemorrhage
  • +5 more
  • Chemical and Mechanical Angioplasty for Refractory Intracranial Arterial Vasospastic Stenosis
  • Brussel, Belgium
    Erasme Hospital
Feb 24, 2022

Alzheimer Trial in Beijing (XTR006)

Recruiting
  • Alzheimer Disease
  • Beijing, Beijing Shi, China
    Chinese PLA General Hospital
Nov 21, 2023

Atherosclerosis, Periodontitis Trial in Catania (Non-surgical periodontal treatment)

Recruiting
  • Atherosclerosis
  • Periodontitis
  • Non-surgical periodontal treatment
  • Catania, Italy
    AOU Policlinico G. Rodolico
Jun 7, 2023

Relapsed or Refractory Non-Hodgkin's Lymphoma Trial in China (AXT-1003)

Not yet recruiting
  • Relapsed or Refractory Non-Hodgkin's Lymphoma
  • Beijing, China
  • +3 more
Jul 20, 2023

Chronic Kidney Disease Trial (HRS-1780)

Not yet recruiting
  • Chronic Kidney Disease
  • (no location specified)
Sep 14, 2023

Atherosclerosis, Endothelial Dysfunction, Peri-Implantitis Trial in Catania (Non-surgical periodontal treatment)

Recruiting
  • Atherosclerosis
  • +3 more
  • Non-surgical periodontal treatment
  • Catania, Italy
    AOU Policlinico G. Rodolico
Jun 7, 2023

Lipodystrophy, Dunnigan Syndrome Trial in Saint-Pierre (Bood and urine sampling)

Recruiting
  • Lipodystrophy
  • Dunnigan Syndrome
  • Bood and urine sampling
  • Saint-Pierre, Réunion
    CHU La Réunion DRCI
Oct 27, 2023

Coronary Microvascular Dysfunction, Microvascular Angina, Vasospasm, Coronary Trial in Germany, Switzerland (Bisoprolol,

Recruiting
  • Coronary Microvascular Dysfunction
  • +5 more
  • Bad Nauheim, Germany
  • +14 more
Mar 15, 2022

Non-proliferative Diabetic Retinopathy Trial (OTX-TKI, Sham)

Not yet recruiting
  • Non-proliferative Diabetic Retinopathy
  • (no location specified)
Jan 12, 2023

Non-Alcoholic Fatty Liver Disease Trial in Hong Kong (SIM01)

Recruiting
  • Non-Alcoholic Fatty Liver Disease
  • SIM01
  • Hong Kong, Hong Kong
    GenieBiome Limited
May 22, 2023

NON-ALCOHOLIC STEATOHEPATITIS Trial in United States (DA-1241, Sitagliptin, DA-1241 Placebo)

Recruiting
  • NON-ALCOHOLIC STEATOHEPATITIS
  • Rialto, California
  • +5 more
Sep 19, 2023

Healthy Volunteer Study Trial in San Antonio (CBP-4888, Placebo)

Recruiting
  • Healthy Volunteer Study
  • San Antonio, Texas
    Comanche Biopharma Clinical Research Site #1
Jun 1, 2023

Cardiogenic Acute Pulmonary Edema in Subjects Over 75 Years Old:

Recruiting
  • Cardiogenic Pulmonary Edema
    • Strasbourg, France
      Gériatrie - Service de Soins de Soins Médicaux et de Réadaptatio
    Oct 24, 2023

    Non-Hodgkin Lymphoma Trial in Taiwan, United States (CHO-H01)

    Recruiting
    • Non-Hodgkin Lymphoma
    • CHO-H01
    • The Woodlands, Texas
    • +7 more
    Jul 10, 2023

    NSCLC, Brain Tumors Trial (bevacizumab, First-Line Chemotherapy Agents, Second-Line Chemotherapy Agents)

    Completed
    • Non-Small Cell Lung Cancer
    • Brain Neoplasms
    • (no location specified)
    Dec 9, 2022

    Flatfoot Trial in Madrid (Bilateral pressure release in Flexor Brevis Digitorum in subjects with latent trigger point, Bilateral

    Completed
    • Flatfoot
    • Bilateral pressure release in Flexor Brevis Digitorum in subjects with latent trigger point
    • Bilateral non emission Laser in latent trigger points of the Flexor digitorum Brevis Muscle
    • Madrid, Spain
      Eva María Martínez-Jimenez
    May 31, 2023

    Multiple Sclerosis, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive Trial in Palo Alto

    Not yet recruiting
    • Multiple Sclerosis
    • +2 more
    • KYV-101 anti-CD19 CAR-T cell therapy
    • Standard lymphodepletion regimen
    • Palo Alto, California
      Stanford Multiple Sclerosis Center
    Nov 13, 2023

    Healthy Trial in Edegem (BI 765845, Placebo)

    Completed
    • Healthy
    • BI 765845
    • Placebo
    • Edegem, Belgium
      SGS Life Science Services - Clinical Research
    Nov 27, 2023

    Non Small Cell Lung Cancer Trial in Shanghai (CS1001 mAb, CS1001 )

    Active, not recruiting
    • Non Small Cell Lung Cancer
    • CS1001 monoclonal antibody
    • CS1001 placebo
    • Shanghai, Shanghai, China
      Shanghai Pulmonary Hospital
    Nov 8, 2022

    NSCLC Trial (BR790+anlotinib)

    Not yet recruiting
    • Non-Small Cell Lung Cancer
    • (no location specified)
    Feb 8, 2023

    NonHodgkin's Lymphoma Refractory Trial in El Segundo (N803, CD19t-haNK suspension, Cyclophosphamide)

    Not yet recruiting
    • NonHodgkin's Lymphoma Refractory
    • El Segundo, California
      CSSIFM
    Nov 9, 2022

    Non-valvular Atrial Fibrillation Trial in Hangzhou (Dual antiplatelet, Novel oral anticoagulant)

    Recruiting
    • Non-valvular Atrial Fibrillation
    • Dual antiplatelet
    • Novel oral anticoagulant
    • Hangzhou, Zhejiang, China
      2nd Affiliated Hospital, School of Medicine at Zhejiang Universi
    Feb 27, 2023

    Elder Trial in Jinan (SIM0417/Ritonavir)

    Recruiting
    • Elder
    • Jinan, Shandong, China
      Shandong First Medical University
    Apr 20, 2023

    NSCLC, NSCLC Stage IV, NSCLC Stage IIIB Trial (MYTX-011)

    Not yet recruiting
    • NSCLC
    • +5 more
    • (no location specified)
    Dec 7, 2022

    NSCLC Trial in Guangzhou (SKB264, Pembrolizumab, Carboplatin)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • Guangzhou, Guangdong, China
      Sun Yat-sen University, Cancer Center
    Apr 14, 2023